Expression of bcl-2, Bax and Fas in oxyphil cells of Hashimoto thyroiditis

Virchows Archiv

Volumn 436, Issue 6, 2000, Pages 602-607

  Muller Hocker J ^a  

^a UNIVERSITY OF MUNICH   (Germany)

Author keywords

Bax; Bcl 2; Fas; Hashimoto thyroiditis; Immunohistochemistry; Oxyphil cell; Thyroid

Indexed keywords

FAS ANTIGEN; PROTEIN BAX; PROTEIN BCL 2;

ADULT; AGED; ARTICLE; CANCER CELL; CELL INFILTRATION; CLINICAL ARTICLE; CONTROLLED STUDY; EPITHELIUM CELL; FEMALE; HASHIMOTO DISEASE; HUMAN; HUMAN TISSUE; IMMUNOREACTIVITY; LYMPHOCYTIC INFILTRATION; LYMPHOID CELL; MALE; MITOCHONDRION; PRIORITY JOURNAL; PROTEIN EXPRESSION; THYROID CELL; THYROID PARAFOLLICULAR CELL;

ADULT; AGED; BCL-2-ASSOCIATED X PROTEIN; FAS LIGAND PROTEIN; FEMALE; HUMANS; MALE; MEMBRANE GLYCOPROTEINS; METAPLASIA; MIDDLE AGED; PROTO-ONCOGENE PROTEINS; PROTO-ONCOGENE PROTEINS C-BCL-2; THYROID GLAND; THYROIDITIS, AUTOIMMUNE;

EID: 0034043074     PISSN: 09456317     EISSN: None     Source Type: Journal    
DOI: 10.1007/s004280000188     Document Type: Article

References (64)

1. 1. Baretton GB, Diebold J, Christotoris G, et al (1996) Apoptosis and immunohistochemical bcl-2 expression in colorectal adenomas and carcinomas. Cancer 77:255-264
2. 2. Bertini E, Vici CD, Servidei S, et al (1992) Fatal infantile liver failure associated with mitochondrial DNA depletion. J Pediatr 121:896-901
3. 3. Boise LH, Gonzales-Garcia M, Postema CE et al. (1993) bcl-x, a bcl-2-related gene that functions as a dominant regulator of apoptotic cell death. Cell 74:597-608
4. 4. Bubendorf L, Sauter G, Moch H, et al (1996) Prognostic significance of bcl-2 in clinically localized prostate cancer. Am J Pathol 148:1557-1565
5. 5. Chen M, Quintans J, Fuks Z, et al (1995) Suppression of Bcl-2 messenger RNA production may mediate apoptosis after ionizing radiation, tumor necrosis factor alpha and ceramide. Cancer Res 55:991-994
6. 6. Dalacas MC, Pezeshkpour I, et al (1990) Mitochondria myopathy caused by longterm zidovudine therapy. N Engl J Med 322:1098-1105
7. 7. Demonacos C, Karayanni N, Hatzoglou E, et al (1996) Mitochondrial genes as sites of primary action of steroid hormones. Steroids 61:226-232
8. 8. Diebold J, Baretton G, Felchner M, et al (1996) bcl-2-expression, p53 accumulation, and apoptosis in ovarian carcinomas. Am J Clin Pathol 105:341-349
9. 9. Fogt F, Vortmeyer AO, Poremba C, et al (1998) Bcl-2 expression in normal adrenal glands and in adrenal neoplasms. Mod Pathol 11:716-720
10. 10. Giordano C, Stassi G, De Maria R, et al (1997) Potential involvement of Fas and its ligand in the pathogenesis of Hashimoto's thyroiditis. Science 275:960-963
11. 11. Gorczyca W, Markiewski M, Kram A, et al (1995) Immunohistochemical analysis of bcl-2 and p53 expression in breast carcinomas: their correlation with Ki-67 growth fraction. Virchows Arch 426:229-233
12. 12. Green DR, Reed JC, et al (1998) Mitochondria and apoptosis. Science 281:1309-1312
13. 13. Haldar S, Negrini M, Monne M, et al (1994) Down-regulation of bcl-2 by p53 in breast cancer cells. Cancer Res 54:2095-2097
14. 14. Hammond LJ, Lowdell MW, Cerrano PG, et al (1997) Analysis of apoptosis in relation to tissue destruction associated with Hashimoto's autoimmune thyroiditis. J Pathol 182:138-144
15. 15. Hashimoto H (1962) Zur Kenntnis der lymphomatösen Veränderungen der Schilddrüse (Struma lymphomatosa). Arch Klin Chir 97:219-248
16. 16. Hashizume K, Ichikawa K (1982) Localization of 3,5,3'-L-triiodothyronine receptor in rat kidney mitochondrial membranes. Biochem Biophys Res Commun 106:920-926
17. 17. Hockenbery DM, Zutter M, Hickey W, et al (1991) Bcl-2 is topographically restricted in tissues characterized by apoptotic cell death. Proc Natl Acad Sci USA 88:6961-6965
18. 18. Jacobson MD, Burne JF, King MP, et al (1993) Bcl-2 blocks apoptosis in cells lacking mitochondrial DNA. Nature 361: 365-369
19. 19. Joensuu H, Phylkkänen L, Toikkanen S (1994) bcl-2-protein expression and long-term survival in breast cancer. Am J Pathol 145:1191-1198
20. 20. Kawakami A, Eguchi K, Matsuoka N, et al (1996) Thyroid-stimulating hormone inhibits Fas antigen-mediated apoptosis of human thyrocytes in vitro. Endocrinology 137:3163-3169
21. 21. Koh EA, Illingworth PJ, Duncan WC, et al (1995) Immunolocalization of bcl-2 protein in human endometrium in the menstrual cycle and simulated early pregnancy. Hum Reprod 10: 1557-1562
22. 22. Krajewski S, Tanaka S, Takayama S, et al (1993) Investigation of the subcellular distribution of the bcl-2 oncoprotein: residence in the nuclear envelope, endoplasmic reticulum, and outer mitochondrial membranes. Cancer Res 53:4701-4714
23. 23. Kroemer G, Zamzami N, Susin SA (1997) Mitochondrial control of apoptosis. Immunol Today 18:44-51
24. 24. Ledgerwood EC, Prins JB, Bright NA, et al (1998) Tumor necrosic factor is delivered to mitochondria where a tumor necrosis factor-binding protein is localized. Lab Invest 78:1583-1589
25. 25. Leek RD, Kaklamanis L, Pezella F, et al (1994) bcl-2 in normal human breast and carcinoma, association with oestrogen receptor-positive, epidermal growth factor receptor-negative tumours and in situ cancer. Br J Cancer 69:135-139
26. 26. Lewis W, Dalacas MC (1995) Mitochondrial toxicity of anti-viral drugs. Nat Med 1:417-422
27. 27. Lu QL, Poulson R, Wong L, et al (1993) Bcl-2 expression in adult and embryonic non-haematopoietic tissues. J Pathol 169:431-437
28. 28. Lu QL, Abel P, Foster CS, et al (1996) Bcl-2 role in epithelial differentiation and oncogenesis. Hum Pathol 27:102-110
29. 29. Maciejewski J, Selleri C, Anderson S, et al (1995) Fas antigen expression on CD 34+ human marrow cells is induced by interferon gamma and tumor necrosis factor alpha and potentiates cytokine mediated hematopoietic supression in vitro. Blood 85:3183-3190
30. 30. Manetto V, Lorenzini R, Cordon-Cardo C, et al (1997) Bcl-2 and bax expression in thyroid tumours. An immunohistochemical and Western blot analysis. Virchows Arch 430:125-130
31. 31. Marchetti Ph, Susin SA, Decaudin D, et al (1996) Apoptosis-associated derangement of mitochondrial function in cells lacking mitochondrial DNA. Cancer Res 56:2033-2038
32. 32. Mitsiades N, Poulaki V, Kotoula V, et al (1998) Fas/Fas ligand up-regulation and Bcl-2 down regulation may be significant in the pathogenesis of Hashimoto's thyroiditis. J Clin Endocrinol Metab 83:2199-2203
33. 33. Miyashita T, Krajewski S, Krajewska M, et al (1994) Tumor supressor p53 is a regulator of bcl-2 and bax gene expression in vitro and in vivo. Oncogene 9:1799-1805
34. 34. Monaghan P, Robertson D, Amos TAS, et al (1993) Ultrastructural localization of bcl-2 Protein. J Histochem Cytochem 40:1819-1825
35. 35. Moraes CT, Shanske S, Tritschler HJ, et al (1991) MtDNA depletion with variable tissue expression: a novel abnormality in mitochondrial disease. Am J Hum Genet 48:492-501
36. 36. Morais R, Zinkewich-Péotti K, Parent M, et al (1994) Tumor-forming ability in athymic nude of human cell lines devoid of mitochondrial DNA. Cancer Res 54:3889-3896
37. 37. Müller-Höcker J (1999) Immunoreactivity of p53, Ki 67 and Bcl2 in oncocytic adenomas and carcinomas of the thyroid gland. Hum Pathol 30:926-933
38. 38. Müller-Höcker J, Jacob U, Seibel P (1998) Hashimoto thyroiditis is associated with defects of cytochrome-c oxidase in oxyphil Askanazy cells and with the common deletion (4.977) of mitochondrial DNA. Ultrastruct Pathol 22:91-100
39. 39. Müller-Höcker J, Schäfer A, Strowitzki T (1998) Glucose transporter 4 (Glut 4) is highly expressed in mitochondria rich oxyphil cells. Appl Immunohistochem 6:224-227
40. 40. Nakamura S, Akazawa K, Kinukawa N, et al (1996) Inverse correlation between the expression of bcl-2 and p53 proteins in primary gastric lymphoma. Hum Pathol 27:225-233
41. 41. Nakopoulou L, Vourlakou C, Zervas A, et al (1996) The prevalence of bcl-2, p53, and Ki-67 immunoreactivity in transitional cell bladder carcinomas and their clinicopathologic correlates. Hum Pathol 29:146-154
42. 42. Nesland JM, Sobrinho-Simoes MA, Hohn R, et al (1985) Hürthle-cell lesions of the thyroid: a combined study using transmission electron microscopy, scanning electron microscopy, and immunocytochemistry. Ultrastruct Pathol 8:269-290
43. 43. Nève P (1969) The ultrastructure of thyroid in chronic autoimmune thyroiditis. Virchows Arch [A] 346:302-317
44. 44. Oehm A, Berhmann I, Falk W, et al (1992) Purification and molecular cloning of the APO-1 cell surface antigen, a member of the TNF/NGF receptor superfamily. J Biol Chem 267:10709-10715
45. 45. Oltvai Z, Milliman C, Korsmeyer SJ (1993) Bcl-2 heterodimerizes in vivo with a conserved homolog, Bax, that accelerates programmed cell death. Cell 74:609-619
46. 46. Pezella F, Turley H, Kuzu I, et al (1993) Bcl-2 protein in non-small-cell lung carcinoma. N Engl J Med 329:690-694
47. 47. Pezella F, Morrison H, Jones M, et al (1993) Immunohistochemical detection of p53 and bcl-2 proteins in non-Hodgkin's lymphoma. Histopathology 22:39-44
48. 48. Pilotti S, Collini P, del Bo R, et al (1994) A novel panel of antibodies that segregates immunocytochemically poorly differentiated carcinoma from undifferentiated carcinoma of the thyroid gland. Am J Surg Pathol 18:1054-1064
49. 49. Pilotti S, Collini P, Rilke F, et al (1994) Bcl-2 protein expression in carcinomas originating from the follicular epithelium of the thyroid gland. J Pathol 172:337-342
50. 50. Reith A (1973) The influence of triiodothyronine and riboflavin deficiency on the rat liver with special reference to mitochondria. Lab Invest 29:216-228
51. 51. Reith A, Brdiczka D, Nolte J, et al (1973) The inner membrane of mitochondria under influence of triiodothyronine and riboflavin deficiency in rat heart muscle and liver. Exp Cell Res 77:1-14
52. 52. Riparbelli MG, Callaini G, Tripodi SA, et al (1995) Localization of the bcl-2 protein to the outer mitochondrial membrane by electron microscopy. Exp Cell Res 221:363-369
53. 53. Saegusa M, Takano Y, Hashimura M, et al (1995) The possible role of bcl-2 expression in the progression of tumors of the uterine cervix. Cancer 76:2297-2303
54. 54. Saegusa M, Takano Y, Okayasu I (1995) Bcl-2 expression and its association with cell kinetics in human gastric carcinomas and intestinal metaplasia. J Cancer Res Clin Oncol 121: 357-363
55. 55. Silvestrini R, Veneroni S, Daidone MG, et al (1994) The BC1-2-protein: a prognostic indicator strongly related to p53 protein in lymph node-negative breast cancer patients. J Natl Cancer Inst 86:499-504
56. 56. Sterling K, Milch PO, Brenner MA, et al (1977) Thyroid hormone action: the mitochondrial pathway. Science 197:996-999
57. 57. Suzuki A, Matsuzawa A, Iguchi T (1996) Down-regulation of Bcl-2 is the first step on Fas-mediated apoptosis of male reproductive tract. Oncogene 13:31-37
58. 58. Tsujimoto Y, Cossmann J, Jaffe E, et al (1985) Involvement of the bcl-2 gene in human follicular lymphoma. Science 228: 1440-1443
59. 59. Tsujimoto Y, Croce CM (1986) Analysis of the structure, transcripts, and protein products of bcl-2, the gene involved in human follicular lymphoma. Proc Natl Acad Sci USA 83: 5214-5218
60. 60. Vormier V, Rötig A, Quartino AR et al. (1990) Widespread multitissue deletions of the mitochondrial genome in the Pearson marrow-pancreas syndrome. Clin Lab Obstet 117: 599-602
61. 61. Watanabe H, Kanzaki H, Narukawa S, et al (1997) bcl-2 and Fas expression in eutopic and ectopic human endometrium during the menstrual cycle in relation to endometrial cell apoptosis. Am J Obstet Gynecol 176:360-368
62. 62. Wrutniak C, Cabello G (1996) La voie d'action mitochondriale directe de la triiodothyronine mythe ou réalité? Med Sci 12:475-484
63. 63. Wrutniak C, Cassar-Malet I, Marschal S, et al (1995) A 43-kDa protein related to c-Erb A alpha 1 is located in the mitochondrial matrix of rat liver. J Biol Chemistry 270: 16347-16357
64. 64. Wyllie AM (1995) The genetic regulation of apoptosis. Curr Opin Genet Dev 5:97-104